Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

Mid-40s woman discharged after heart failure without impaired brain function thanks to personalized CARL therapy.

In a situation where further attempts of resuscitation previously seemed futile, CARL can still help. Controlled whole-body reperfusion also benefited a woman who suddenly felt a stabbing pain in her chest and collapsed while gardening on a friendly summer day.

Her husband reacted quickly. He called 112 and immediately began chest compressions. This was continued and extended by emergency medical measures until the woman in her mid-forties was finally admitted to hospital. In total, about two hours passed before the patient, still without her own cardiac circuit, was connected to the system. Thanks to personalized extracorporeal circulation, it was possible to diagnose and treat the reason for the heart failure – and after only 21 days, the woman could be discharged without any restrictions on brain function.